ASCO Annual Meeting

Drug Combination Is Effective in Urothelial Carcinoma

June 6th 2017, 10:06pm

Article

When combined with the IDO1 inhibitor epacadostat, Keytruda (pembrolizumab), a PD-1 inhibitor, resulted in an overall response rate (ORR) of 35 percent in patients with advanced urothelial carcinoma, according to results from the phase 1/2 ECHO-202/KEYNOTE-037 trial.

Therapy Shows High Remission Rates in Multiple Myeloma

June 6th 2017, 5:59pm

Article

Many patients with relapsed or refractory multiple myeloma saw clinical remission with CAR T-cell therapy.

Will There Be an Immunotherapy Approval in Gastric Cancer?

June 5th 2017, 9:55pm

Article

Keytruda (pembrolizumab) showed promising signs of clinical activity for patients with advanced gastric or gastroesophageal junction (GEJ), according to updated findings from KEYNOTE-059 study that were presented at the 2017 American Society for Clinical Oncology (ASCO) Annual Meeting.

New Agent Shows Promise Across Many Cancers Which Have TRK Fusion Mutations

June 5th 2017, 6:48pm

Article

Promising results from a new agent may set the stage for a new standard of care for patients with TRK fusion mutations.

With Patients Reporting Symptoms Using Web Tool, Survival Improves

June 4th 2017, 10:21pm

Article

An online tool helped patients to report their symptoms in real time, improving survival, according to findings presented at ASCO 2017.

Patients With Low-Risk Colon Cancer Can Have Less Chemotherapy, Reducing Neuropathy

June 4th 2017, 10:06pm

Article

According to findings presented at ASCO 2017, patients with low-risk advanced colon cancer would benefit from reducing the length of chemotherapy after surgery.

Staying CALM: Psychotherapy for Patients with Advanced Cancers

June 4th 2017, 8:19pm

Article

The psychotherapty known as CALM has been shown to ease depression and distress in patients with advanced cancer.

Maintaining Mobility May Not Require More Than Single-Dose Radiation

June 4th 2017, 5:59pm

Article

According to phase III findings presented at ASCO 2017, single radiation treatment relieved the symptoms of spinal cord compression in patients with advanced cancer as effectively as a five-day course.

Study Finds a Decline in Late Effects After Childhood Treatment

June 3rd 2017, 8:38pm

Article

There are fewer reported incidences of severe long-term side effects after childhood cancer treatment, according to a recent study.

Psychological Interventions Can Lower Fear of Recurrence

June 2nd 2017, 11:47pm

Article

A recent clinical trial showed that psychological intervention can ease patients' anxiety and fear of recurrence.